PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database.

Front Immunol · 2025 · PMC11794220 · PMID 39911399

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

By contrast, the IC of PDL1 inhibitors did not reach statistical significance: -2.6 [-6.4;-1.0], with 1 report observed as compared to 9 expected.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.